NCT02260570View on ClinicalTrials.gov

Remediation of Impaired Self-Regulation in Patients With Mild TBI

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

August 1, 2015

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
Mild Traumatic Brain Injury
Interventions
DRUG

Tolcapone

COMT Inhibitor

DRUG

Placebo

A pill that contains no active ingredient

Trial Locations (1)

95655

VA Northern California Health Care System, Mather, CA, Sacramento

All Listed Sponsors
collaborator

University of California, Berkeley

OTHER

collaborator

University of California, San Francisco

OTHER

lead

VA Office of Research and Development

FED

NCT02260570 - Remediation of Impaired Self-Regulation in Patients With Mild TBI | Biotech Hunter | Biotech Hunter